Hao Liu is a researcher affiliated with institutions like Chinese Academy of Sciences , Beihang University , and Stanford University . His work spans Computer Science , Artificial Intelligence , and Robotics . Key affiliations: National Space Science Center (Beijing), School of Astronautics (Beihang), Key Laboratory of Pervasive Computing (Tsinghua) Research interests include Machine Learning , Image Processing , Graph Neural Networks , and Wireless Communication Optimization His recent publications focus on: Advanced control systems for fuzzy models Medical imaging via hyperspectral analysis Transformer-based approaches in NLP and vision Quantum-safe and edge computing protocols
Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.
Shahram Rahimi is a Professor and Department Head in the Department of Computer Science at the University of Alabama, College of Engineering. He concurrently holds an Adjunct Professor position at Mississippi State University. His research spans computational intelligence, machine learning, healthcare AI, cybersecurity, and quantum computing. He leads the PATENT Lab, focusing on predictive analytics, decision support systems, and AI-driven healthcare solutions. His educational background includes a Ph.D. in Computer Science. Key research areas include multi-agent systems, generative models, and predictive maintenance. He has served as an editor for journals like Scalable Computing: Practice and Experience and Informatica . Rahimi’s recent work emphasizes secure MLOps, quantum algorithms, and patient-centric medical systems. His publications address challenges in explainable AI, anomaly detection, and healthcare informatics. He actively contributes to conferences and journals in AI, cybersecurity, and computational intelligence. Editorial Roles: Scalable Computing, Engineering Letters, Informatica Labs: Predictive Analytics & Technology Integration (PATENT) Lab Key Focus Areas: Healthcare AI, Quantum Computing, Cybersecurity, Explainable Machine Learning
Søren Lundbye-Christensen is an Associate Professor and Biostatistician affiliated with the Clinical Institute at the Faculty of Health Sciences, Aalborg University, and Aalborg University Hospital in Denmark. He specializes in biostatistical support for medical research, with a strong emphasis on cardiovascular and epidemiological studies. His research interests include biostatistics, survival analysis, cohort studies, clinical epidemiology, and statistical modeling in public health. He has contributed to a wide array of healthcare research, particularly in cardiovascular diseases, cancer, maternal health, and infectious diseases. His methodological expertise spans time-to-event analysis, registry-based research, and interval-censored data modeling. The recent publications highlight a strong trend in applying advanced statistical methods to large-scale clinical and population-based datasets. His work often involves collaboration with medical researchers to derive prognostic models, validate clinical databases, and assess public health outcomes. Key themes include cardiovascular risk, fertility, cancer biomarkers, and implementation of medical training programs. Scientific Contributions and Recognition: Published over 320 research articles and datasets. Active contributor to methodological advancements in biostatistics. Regular peer reviewer, including for journals like the R Journal. Public engagement through media appearances on statistics and health. Academic Advising and Grants: Søren has supervised 31 student theses, formally serving as PhD supervisor for 14 theses and as a biostatistical advisor for 19 others, primarily in mathematics and statistics. He has participated in numerous research projects funded through institutional and national grants, including studies on seasonal disease trends, postoperative complications, and metabolic disease prediction. His work often involves interdisciplinary collaboration across medicine, public health, and data science. Labs and Research Teams: He is embedded in collaborative research networks at Aalborg University Hospital and Aalborg University, contributing statistical expertise to clinical research groups. He is involved in projects utilizing Danish national health registries and has contributed to the development and validation of clinical databases. His work supports both hypothesis-driven medical research and methodological innovation in biostatistics.
Professor Carlos Caldas is a leading academic in cancer medicine, affiliated with the University of Cambridge as a Professor of Cancer Medicine in the Department of Oncology . His research focuses on functional genomics of breast cancer, redefining its molecular taxonomy, studying clonal heterogeneity, and pioneering ctDNA as a liquid biopsy biomarker. MD (Lisbon), PhD (Porto, Honoris Causa) Member of the School of Clinical Medicine His laboratory has developed patient-derived tumor explants and advanced computational models for biomarker discovery. Recent work integrates AI with spatial transcriptomics and histopathology for precision oncology. Scientific Awards : Fellow of the Academy of Medical Sciences (FMedSci)
Guadalupe Garcia-Tsao is a Professor of Medicine at Yale University's Yale School of Medicine and past Chief of Digestive Diseases at the VA-Connecticut Healthcare System. She is also an Associate Editor of the New England Journal of Medicine and former President of the American Association for the Study of Liver Diseases (AASLD). Her work focuses on the complications of cirrhosis, particularly portal hypertension, variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. She has authored over 200 peer-reviewed publications and co-edited major textbooks in gastroenterology and hepatology. Education: M.D. from Universidad Nacional Autónoma de México (1977) Internal Medicine Residency at Instituto Nacional de la Nutrición (1980) Gastroenterology Fellowship at Instituto Nacional de la Nutrición (1982) Hepatology Training at Yale University (1985) Research Interests: Her research emphasizes patient-oriented studies in cirrhosis complications, including portal hypertension management, variceal bleeding prevention, and ascites treatment. She explores innovative approaches like AI-driven diagnostic tools and biomarker discovery for alcohol-associated hepatitis. Her work bridges clinical practice and translational science to improve outcomes for liver disease patients. Awards: EASL International Recognition Award (2014) AASLD Clinician Educator and Mentor Achievement Award (2015) 2023 ALEH Mentor Award Advising & Grants: Dr. Garcia-Tsao mentors junior faculty and trainees, emphasizing clinical and translational research. She leads grants focused on cirrhosis pathophysiology, including studies on AI in liver disease and global cohort analyses for alcohol-associated hepatitis. Notable collaborations include work with the International Club of Ascites and ADQI initiatives. Labs & Teams: She directs the Clinical and Translational Core of the Yale Liver Center and collaborates with the VA-CT Healthcare System on translational projects. Her team investigates liver dysfunction mechanisms and develops novel therapeutic strategies for advanced liver disease.
Knut Håkon Hole is an Associate Professor at the University of Oslo's Department of Radiology and Nuclear Medicine. His research focuses on diagnostic imaging applications in oncology, particularly in prostate and rectal cancers. He specializes in MRI, PET, and radiogenomics techniques to assess tumor biology, treatment response, and recurrence. Expertise: Prostate cancer imaging, neoadjuvant therapy response, tumor hypoxia, and imaging biomarkers Key affiliations: Oslo University Hospital (Rikshospitalet), Radium Hospital Research interests include: Developing MRI and PET protocols for cancer staging and recurrence detection Integrating imaging with genomic data (radiogenomics) Optimizing therapeutic approaches using imaging biomarkers Recent work highlights: Prostate cancer radiogenomics and hypoxia biomarkers (2024) MRI/PET comparisons for tumor localization (2021-2023) Neoadjuvant therapy response assessment in rectal and breast cancers (2020-2023) Publications span over 50 peer-reviewed articles with a focus on translational imaging research. Collaborates extensively with oncology and urology teams.
Dr. Eric Meyers is an Assistant Professor in the Department of Bioengineering at the Erik Jonsson School of Engineering and Computer Science, University of Texas at Dallas. He holds a Ph.D. in Biomedical Engineering and dual Bachelor's/Master's degrees in Electrical Engineering from the same institution. His research focuses on closed-loop neurotechnology, neuromodulation, and bioelectronic medicine to enhance recovery from nervous system injuries. Key projects include developing wearable EMG sleeves for stroke rehabilitation and closed-loop neuromodulation systems to restore motor function. Education: B.S. (2012), M.S. (2018), Electrical Engineering; Ph.D. (2017), Biomedical Engineering – all from UTD His research interests span machine learning applications in neurorehabilitation, biomarker discovery for neurological conditions, and clinical translation of bioelectronic therapies. Recent work emphasizes wearable devices for real-time motor function assessment and neuromodulation-driven recovery strategies. Publications highlight advancements in EMG-based neural interfaces, closed-loop algorithms for stroke therapy, and innovative FES systems. His lab actively collaborates on projects funded by NIH and industry partnerships, with a focus on translating technologies to clinical settings.
Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.
Professor Peter van der Voort is the Head of the Department of Intensive Care at the Faculty of Medical Sciences, University of Groningen, and holds a joint appointment as Professor of Health Care at Tilburg University. He is also an Academic Director of the Executive Master Health Administration program at TIAS School for Business and Society. Additionally, he serves as a Member of the Dutch Senate, balancing academic and political roles. Research Focus: His research primarily revolves around critical care medicine, particularly in the context of severe illnesses like COVID-19. Key areas include extracellular matrix dynamics in critical illness, clinical outcomes in ICU patients, and the impact of comorbidities such as obesity on disease severity. He has contributed to studies on corticosteroid therapy efficacy, renal function biomarkers, and the immunopathological mechanisms of viral infections in transplant recipients. Publications & Awards: Over 80 peer-reviewed articles in journals like Respiratory Research , Scientific Reports , and Critical Care highlight his expertise. His work emphasizes translational research bridging clinical care and public health policy. Notably, he pioneered methodologies for predicting mortality in critically ill patients using machine learning and advanced biomarker analysis. Affiliations & Leadership: Beyond academia, he leads the Netherlands’ Palliative Care Association and has been featured in media for his commentary on healthcare optimization and cost-efficiency strategies. His dual role in politics and medicine underscores his commitment to improving healthcare systems through evidence-based policies.
Adrien Depeursinge is a Professor at HES-SO Valais-Wallis - Haute Ecole de Gestion, affiliated with the School of Economics and Services and the Management Information Systems department. His research focuses on radiomics, personalized medicine via image-based analysis, and clinical workflow optimization. He leads the development of the QuantImage platform, a physician-centered web-based tool for radiomics research, and contributes to radiomics standardization efforts through initiatives like the Image Biomarker Standardization Initiative (IBSI). His work emphasizes machine learning applications in healthcare, including tumor segmentation, biomarker extraction, and improving diagnostic accuracy through computational models. Key research themes include: 1) Radiomics – developing quantitative imaging features for cancer diagnosis/prognosis; 2) Medical Imaging Analysis – advancing texture-based models, multi-modal fusion, and automated lesion detection; 3) Physician-AI Collaboration – designing user-centric tools for clinical integration. His contributions span neuro-oncology (brain metastases), head-and-neck cancer, and multiple sclerosis imaging. Publications emphasize methodological advancements (e.g., kernel optimization in CNNs, steerable detectors) and clinical validation (e.g., reproducibility of radiomics features across imaging protocols). He collaborates with institutions like the University Hospital of Lausanne (CHUV) and international teams on projects like the HECKTOR challenge for PET/CT tumor segmentation. His work bridges technical innovation with clinical impact, aiming to translate radiomics into actionable clinical tools. QuantImage v2, his flagship tool, enables no-code development of machine learning models using clinical imaging data. Research also includes phantom-based validation of radiomics features and addressing challenges in feature stability across imaging modalities. Current projects explore improving contour quality for radiomics studies and optimizing AI explainability in medical decision-making.
Dr. Alexander Breuss is part of the Sensory-Motor Systems Professorship at ETH Zürich, focusing on developing innovative robotic and sensor technologies for medical applications, particularly in sleep disorder treatment and home healthcare. His work integrates biomedical engineering, robotics, and machine learning to address challenges in sleep medicine and cardiovascular diagnostics. Key projects include the Somnomat Care robotic bed for vestibular stimulation and the Somnomat Casa system for nocturnal interventions. His research spans sensorized devices for sleep monitoring, clinical trials for rhythmic movement disorders, and cardiovascular disease prognosis using imaging and hemodynamic analysis. Dr. Breuss collaborates on interdisciplinary projects, combining engineering and clinical insights to advance healthcare technologies. His research interests include the design of medical devices for home environments, non-invasive monitoring systems, and closed-loop robotic systems for therapeutic applications. Notable contributions include lightweight wearable sensors for movement disorders and automated sleep position classification using neural networks. He has published extensively on topics such as pleural effusion in aortic stenosis and ECG-based cardiac prognosis, highlighting his cross-disciplinary approach to biomedical challenges. No scientific awards are explicitly mentioned for Dr. Breuss. His work is centered at the Sensory-Motor Systems Lab, where he contributes to advancing technologies that improve patient care and sleep quality through robotics and sensor innovation.
Professor Pantelis Georgiou holds a faculty position in the Department of Electrical and Electronic Engineering at Imperial College London, leading the Bio-inspired Metabolic Technology Laboratory within the Centre for Bio-Inspired Technology. His research focuses on biomedical electronics, lab-on-chip technology, and micro-electronic medical devices. Key contributions include the bio-inspired artificial pancreas for diabetes treatment and CMOS-based pH sensors for DNA sequencing and infectious disease diagnostics. Education: 1st Class Honours MEng (2004) and PhD (2008) in Electrical & Electronic Engineering from Imperial College London. Professional roles include Head of Lab (2010), IEEE Distinguished Lecturer in Circuits and Systems, and Co-founder/Director of ProtonDx. Research interests span ultra-low power microelectronics, bio-inspired circuits, wearable technologies for chronic conditions, and antimicrobial resistance diagnostics. He has pioneered ISFET sensor integration and developed rapid diagnostic platforms for infectious diseases like dengue and mpox. Notable awards include the IET Mike Sergeant Medal (2013) and IEEE Sensors Council Technical Achievement Award (2017). Current projects involve AI-driven clinical decision support systems, antibiotic stewardship tools, and global health technologies for resource-limited settings. Affiliations include the CRUK Convergence Science Centre, Organ-on-chip Network, and Imperial College Network of Excellence in Malaria. His work bridges engineering and medicine, addressing global challenges through interdisciplinary innovation.
Associate Professor Abdul Ihdayhid is a Research Leader in Cardiovascular Biology at the Curtin Medical School , Curtin University, within the Faculty of Health Sciences. His work focuses on advanced cardiac imaging techniques, particularly coronary CT angiography, fractional flow reserve modeling, and AI integration in cardiovascular diagnostics. Key Research Areas: Cardiovascular imaging, artificial intelligence applications, aortic stenosis interventions, and ethical implications of AI in medicine. Recent Publications: Analysis of high-risk coronary plaque, telehealth adaptations during pandemics, and AI-driven CAC scoring innovations. Collaborations: Extensive partnerships with institutions across Australia and New Zealand on multicenter studies like the Australian-New Zealand SCAD cohort. His 2024-2025 work emphasizes machine learning for plaque quantification and ethical frameworks in AI implementation. Email: Abdul.Ihdayhid@curtin.edu.au
Yi Li is the M. Anthony Schork Collegiate Professor of Biostatistics at the University of Michigan School of Public Health. With a PhD in Biostatistics from the University of Michigan (1999) and postdoctoral training at Harvard (1999-2000), Dr. Li has established himself as a leading researcher in statistical methodology with applications across multiple biomedical domains. Dr. Li's research spans survival analysis, data science, high-dimensional inference, machine learning, deep learning, spatial data analysis, random-effects models, clinical trial design, and infectious disease modeling. His methodological work finds application in cancer genetics/genomics, radiomics, racial disparity analysis, chronic disease research, and opioid overuse studies. With over 230 publications in major statistical journals including JASA, Biometrika, JRSSB, and Biometrics, as well as premier subject matter journals like PNAS, JAMA, and JCO, Dr. Li's work has significantly impacted both statistical theory and biomedical applications. His research portfolio demonstrates consistent evolution from foundational methodological work in survival analysis and spatial statistics to cutting-edge applications in high-dimensional data, machine learning, and deep learning approaches for complex biomedical problems. The recent publications reveal increasing focus on integrating multiple data sources, causal inference in observational studies, and developing interpretable machine learning models for clinical applications. Dr. Li's work has been continuously supported by NIH funding since 2003, including multiple National Cancer Institute grants (R01 CA95747, 1P01CA134294-010002, R21CA157219, R01CA249096, R01CA269398) and a National Institute on Aging grant (R21AG058198). He actively collaborates with researchers from the University of Michigan and Harvard University on clinical and observational studies. As an educator, Dr. Li has taught advanced courses in survival analysis and statistical methods, mentoring the next generation of biostatisticians. His methodological contributions have been widely recognized through invitations to serve on NIH study sections (BMRD 2008-2012, EPIC 2015-2019) and as Associate Editor for leading statistical journals including Journal of the American Statistical Association, Biometrics, and Scandinavian Journal of Statistics.
